Amedisys Inc (NASDAQ:AMED) 2017 Q3 Sentiment Report

January 21, 2018 - By Migdalia James

 Amedisys Inc (NASDAQ:AMED)  2017 Q3 Sentiment Report

Sentiment for Amedisys Inc (NASDAQ:AMED)

Amedisys Inc (NASDAQ:AMED) institutional sentiment decreased to 1.71 in 2017 Q3. Its down -0.04, from 1.75 in 2017Q2. The ratio dived, as 94 funds increased or started new positions, while 55 sold and reduced holdings in Amedisys Inc. The funds in our partner’s database now own: 31.75 million shares, up from 30.18 million shares in 2017Q2. Also, the number of funds holding Amedisys Inc in their top 10 positions decreased from 2 to 1 for a decrease of 1. Sold All: 26 Reduced: 29 Increased: 64 New Position: 30.

Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. The company has market cap of $1.89 billion. It operates through three divisions: Home Health, Hospice, and Personal Care. It has a 44.08 P/E ratio. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses, physical and speech therapists, occupational therapists, and aides for its patients to complete their important personal tasks.

The stock increased 1.46% or $0.8 during the last trading session, reaching $55.59. About 161,189 shares traded. Amedisys, Inc. (NASDAQ:AMED) has risen 15.02% since January 21, 2017 and is uptrending. It has underperformed by 1.68% the S&P500.

Analysts await Amedisys, Inc. (NASDAQ:AMED) to report earnings on February, 27. They expect $0.59 EPS, up 34.09 % or $0.15 from last year’s $0.44 per share. AMED’s profit will be $20.03 million for 23.56 P/E if the $0.59 EPS becomes a reality. After $0.56 actual EPS reported by Amedisys, Inc. for the previous quarter, Wall Street now forecasts 5.36 % EPS growth.

Kohlberg Kravis Roberts & Co. L.P. holds 3.15% of its portfolio in Amedisys, Inc. for 4.84 million shares. Copper Rock Capital Partners Llc owns 575,315 shares or 2.14% of their US portfolio. Moreover, Fny Managed Accounts Llc has 1.18% invested in the company for 16,092 shares. The Connecticut-based Sivik Global Healthcare Llc has invested 1.05% in the stock. Redmile Group Llc, a California-based fund reported 283,648 shares.#img1#

Since January 1, 0001, it had 0 insider purchases, and 1 sale for $50,000 activity.

Amedisys, Inc. (NASDAQ:AMED) Ratings Coverage

Ratings analysis reveals 43% of Amedisys Inc.’s analysts are positive. Out of 14 Wall Street analysts rating Amedisys Inc., 6 give it “Buy”, 0 “Sell” rating, while 8 recommend “Hold”. The lowest target is $39 while the high is $68.0. The stock’s average target of $58.73 is 5.65% above today’s ($55.59) share price. AMED was included in 36 notes of analysts from September 1, 2015. As per Friday, January 27, the company rating was initiated by Benchmark. The stock of Amedisys, Inc. (NASDAQ:AMED) earned “Hold” rating by RBC Capital Markets on Monday, June 5. The stock of Amedisys, Inc. (NASDAQ:AMED) earned “Buy” rating by Mizuho on Thursday, November 2. On Sunday, October 22 the stock rating was maintained by RBC Capital Markets with “Hold”. The firm earned “Buy” rating on Thursday, July 27 by Oppenheimer. As per Tuesday, April 5, the company rating was downgraded by Obsidian Research Group. RBC Capital Markets maintained Amedisys, Inc. (NASDAQ:AMED) on Friday, May 6 with “Sector Perform” rating. The company was maintained on Tuesday, September 5 by Jefferies. Raymond James upgraded the shares of AMED in report on Monday, January 11 to “Mkt Perform” rating. SunTrust maintained Amedisys, Inc. (NASDAQ:AMED) on Monday, October 9 with “Buy” rating.

More important recent Amedisys, Inc. (NASDAQ:AMED) news were published by: which released: “Amedisys to Present at the 36th Annual JP Morgan Healthcare Conference” on January 05, 2018, also published article titled: “Amedisys Forges Collaborative Partnership with myNEXUS®”, published: “3 Health Care Stocks With M&A Potential In 2018” on December 22, 2017. More interesting news about Amedisys, Inc. (NASDAQ:AMED) was released by: and their article: “Amedisys Honors 18 with Annual Spirit of Excellence Awards” with publication date: January 10, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: